Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
基本信息
- 批准号:10655351
- 负责人:
- 金额:$ 12.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT: The goals of this K24 proposal are to train clinical investigators in the conduct of patient-oriented
cardiovascular disease (CVD) research primarily in Haiti, with a new project in Tanzania and to conduct a new
study on environmental lead exposure and CVD risk factors in Haiti (Aim 1). The training also leverages four
currently funded CVD research projects in Haiti (Aims 2-5), and a funded CVD research project in Tanzania
(Aim 6). United States trainees will spend ~50-60% of their time at international research sites in Haiti and
Tanzania, which have onsite Weill Cornell faculty, long-standing international collaborators, and outstanding
environments for research training. The common theme of the projects is patient-oriented CVD research in the
areas of clinical epidemiology, clinical trials, CVD-infectious diseases, and implementation science. The
projects include:
1. Environmental lead exposure and CVD risk factors in Haiti
2. Clinical epidemiology of CVD risk factors, diseases, and poverty-related social determinants in Haiti
3. Randomized clinical trial of early hypertension treatment among persons living with HIV
4. COVID-19 and cardiac dysfunction
5. Implementation of hypertensive screening and management
6. Heart failure in Tanzania
The focus of research training will be on postdoctoral clinical investigators who have completed their advanced
degree training. Dr. McNairy has an impeccable history of excellence in research mentorship and serves in
leadership roles in the Weill Cornell Global Health Research Fellowship and the Weill Cornell Women in Global
Health Research Initiative. Trainees will be mentored by Dr. McNairy and will participate in research projects in
Haiti (Aims 1-5) and Tanzania (Aim 6). These six projects have both clinical and laboratory aspects and offer
trainees a broad research experience. Trainees learn through the conduct of their mentored research project
and the opportunity to interact with colleagues working on studies other than their own. The K24 award will
allow Dr. McNairy to decrease her administrative and clinical responsibilities and commit 50% effort to CVD-
related research and mentorship of US trainees. Her long-term goal is to build a world-class CVD global health
research and training program to improve CVD-related health outcomes among the world's poorest
populations.
摘要:该K24提案的目标是培训临床研究人员以患者为导向的
心血管疾病(CVD)研究主要在海地,在坦桑尼亚进行了一个新项目,并进行了新的项目
海地环境铅暴露和CVD风险因素的研究(AIM 1)。培训还利用四个
目前在海地资助的CVD研究项目(AIMS 2-5),以及坦桑尼亚的资助CVD研究项目
(目标6)。美国学员将在海地的国际研究地点花费约50-60%的时间
坦桑尼亚(Tanzania
研究培训的环境。项目的共同主题是面向患者的CVD研究
临床流行病学,临床试验,CVD感染性疾病和实施科学领域。这
项目包括:
1。海地环境潜在客户暴露和CVD风险因素
2。CVD风险因素,疾病和与贫困相关的社会决定因素的临床流行病学
3。艾滋病毒患者早期高血压治疗的随机临床试验
4。COVID-19和心脏功能障碍
5。实施高血压筛查和管理
6。坦桑尼亚的心力衰竭
研究培训的重点将放在已经完成高级的博士后临床研究人员身上
学位培训。 McNairy博士拥有无可挑剔的研究指导历史,并在
Weill Cornell全球健康研究奖学金和Weill Cornell妇女在全球的领导角色
健康研究计划。学员将由McNairy博士指导,并将参加研究项目
海地(目标1-5)和坦桑尼亚(目标6)。这六个项目既有临床和实验室方面,并提供
学员是广泛的研究经验。学员通过他们的指导研究项目的行为学习
以及与自己从事研究以外的其他研究的同事互动的机会。 K24奖将
允许McNairy博士降低她的行政和临床责任,并付出50%的努力来CVD-
美国学员的相关研究和指导。她的长期目标是建立世界一流的CVD全球健康
研究与培训计划,以改善世界上最贫穷的CVD相关的健康成果
人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Margaret Leighton ...的其他基金
Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
- 批准号:1042798810427988
- 财政年份:2022
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:1048316010483160
- 财政年份:2021
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:1030260110302601
- 财政年份:2021
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Cardiovascular Disease Research Training Program in Haiti
海地心血管疾病研究培训项目
- 批准号:1067300210673002
- 财政年份:2021
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in Haiti
在海地治疗艾滋病毒感染者的早期高血压以预防心血管疾病
- 批准号:1025605610256056
- 财政年份:2020
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Social and Environmental Determinants of Hypertension in Adolescents and Youth in Haiti
海地青少年高血压的社会和环境决定因素
- 批准号:1017431510174315
- 财政年份:2018
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:97513759751375
- 财政年份:2018
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:1043566310435663
- 财政年份:2018
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:1065344510653445
- 财政年份:2018
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
评估海地心血管危险因素和疾病的纵向队列研究
- 批准号:1043978010439780
- 财政年份:2018
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
BCCMA: Foundational Research to Act Upon and Resist Conditions Unfavorable to Bone (FRACTURE CURB): Role of Hypertension in Favoring Osteoporosis
BCCMA:针对和抵抗不利于骨骼的条件(骨折遏制)的基础研究:高血压在促进骨质疏松症中的作用
- 批准号:1048357210483572
- 财政年份:2022
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Global Health Research and Training in Cardiovascular Disease
心血管疾病的全球健康研究和培训
- 批准号:1042798810427988
- 财政年份:2022
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
阻断钙通道和 β 肾上腺素能受体可治疗射血分数保留的心力衰竭的生理异常(BLOCK HFpEF)
- 批准号:1003110910031109
- 财政年份:2020
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Treatment of early hypertension in persons living with HIV for cardiovascular disease prevention in Haiti
在海地治疗艾滋病毒感染者的早期高血压以预防心血管疾病
- 批准号:1025605610256056
- 财政年份:2020
- 资助金额:$ 12.42万$ 12.42万
- 项目类别:
Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF)
阻断钙通道和 β 肾上腺素能受体可治疗射血分数保留的心力衰竭的生理异常(BLOCK HFpEF)
- 批准号:1047359410473594
- 财政年份:2020
- 资助金额:$ 12.42万$ 12.42万
- 项目类别: